Showing 1-5 of 10 :
APPLYING BIG DATA ANALYTICS TO PATIENT RECORDS, OM1 OFFERS INSIGHTS TO HOSPITALS AND PHARMA

Published by TechCrunch, December 17 2019, written by Jonathan Shieber OM1, a big-data analytics company for the healthcare industry, has raised $50 million in its latest round of financing to expand its sales and marketing and product development activities as it brings clinical insights to hospitals and big pharma companies alike. The new financing highlights[…]

NEW PROJECT PUTS STANDARDIZED OUTCOMES MEASURES FOR DEPRESSION INTO REAL-WORLD USE, FROM REGISTRIES TO THE CLINIC

New Project Puts Standardized Outcomes Measures for Depression into Real-World Use, from Registries to the Clinic  OM1 partners with AHRQ, ABFM, APA and others to implement  BOSTON, July 17, 2019 —OM1, a leading health outcomes and technology company, today announced it is has been awarded the CAPSTONE – Outcome Measure Harmonization and Data Infrastructure for[…]

BHE & OM1 PARTNER TO DELIVER RHEUMATOLOGY REGISTRIES THROUGH IHD

Research-Grade, Analytic-Ready Rheumatology Data at Your Fingertips through the IHD Platform What would you do with rapid access to analytics and insights from hundreds of thousands of rheumatology patients? Bringing together the largest linked, longitudinal rheumatology condition registries with the industry-leading Instant Health Data (IHD) platform, OM1 and BHE join forces to deliver a powerful[…]

Applying AI for personalized treatment decisions and lowering costs in orthopedics

Becker’s Spine Review | Written by Richard Gliklich, MD, CEO, OM1 | November 26, 2018 In healthcare, results really matter Understanding why certain treatments and procedures work better on some patients and not so well on others is the key to delivering more personalized care and ultimately achieving better results for all stakeholders in the care process.[…]

OM1 Lupus Registry Reaches More Than 25,000 Patients Prospectively Followed With Deep Clinical And Lab Data

OM1 LUPUS REGISTRY REACHES MORE THAN 25,000 PATIENTS PROSPECTIVELY FOLLOWED WITH DEEP CLINICAL AND LAB DATA Ready for collaborations, the registry enables faster, more cost-effective access to research-grade lupus data for better understanding, comparing, and predicting treatment outcomes BOSTON, October 17, 2018 — OM1, a leading health outcomes, registries and technology company creating solutions to[…]